Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Supraventricular tachycardia? 52 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Supraventricular tachycardia have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 0.4% of all adverse event reports for EPOPROSTENOL.

52
Reports of Supraventricular tachycardia with EPOPROSTENOL
0.4%
of all EPOPROSTENOL reports
12
Deaths
46
Hospitalizations

How Dangerous Is Supraventricular tachycardia From EPOPROSTENOL?

Of the 52 reports, 12 (23.1%) resulted in death, 46 (88.5%) required hospitalization, and 8 (15.4%) were considered life-threatening.

Is Supraventricular tachycardia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 52 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Supraventricular tachycardia?

ADALIMUMAB (141) METOPROLOL (132) ROSIGLITAZONE (114) TREPROSTINIL (113) RITUXIMAB (99) ALBUTEROL (98) IBRUTINIB (96) DEXAMETHASONE (95) ASPIRIN (92) LEVOTHYROXINE (91)

Which EPOPROSTENOL Alternatives Have Lower Supraventricular tachycardia Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Supraventricular tachycardia Reports All Drugs Causing Supraventricular tachycardia EPOPROSTENOL Demographics